185 related articles for article (PubMed ID: 10863026)
1. Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.
Kohnken R; Buerger K; Zinkowski R; Miller C; Kerkman D; DeBernardis J; Shen J; Möller HJ; Davies P; Hampel H
Neurosci Lett; 2000 Jun; 287(3):187-90. PubMed ID: 10863026
[TBL] [Abstract][Full Text] [Related]
2. Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification.
Yamamori H; Khatoon S; Grundke-Iqbal I; Blennow K; Ewers M; Hampel H; Iqbal K
Neurosci Lett; 2007 May; 418(2):186-9. PubMed ID: 17400380
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease.
Kapaki EN; Paraskevas GP; Tzerakis NG; Sfagos C; Seretis A; Kararizou E; Vassilopoulos D
Eur J Neurol; 2007 Feb; 14(2):168-73. PubMed ID: 17250725
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphorylated tau protein in the cerebrospinal fluid of patients with Alzheimer's disease and other dementias: preliminary findings.
Hartmann AP; Almeida SM; Livramento JA; Nitrini R; Takahashi D; Caramelli P
Arq Neuropsiquiatr; 2004 Sep; 62(3B):751-5. PubMed ID: 15476062
[TBL] [Abstract][Full Text] [Related]
5. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
6. Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease.
Schönknecht P; Pantel J; Hunt A; Volkmann M; Buerger K; Hampel H; Schröder J
Neurosci Lett; 2003 Mar; 339(2):172-4. PubMed ID: 12614922
[TBL] [Abstract][Full Text] [Related]
7. Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.
Vanderstichele H; De Vreese K; Blennow K; Andreasen N; Sindic C; Ivanoiu A; Hampel H; Bürger K; Parnetti L; Lanari A; Padovani A; DiLuca M; Bläser M; Olsson AO; Pottel H; Hulstaert F; Vanmechelen E
Clin Chem Lab Med; 2006; 44(12):1472-80. PubMed ID: 17163825
[TBL] [Abstract][Full Text] [Related]
8. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
[TBL] [Abstract][Full Text] [Related]
9. [The measurement of phosphorylated tau in human cerebrospinal fluid as a diagnostic marker for Alzheimer's disease].
Urakami K; Ito N; Arai H; Ishiguro K; Ohno H; Nakashima K
Seishin Shinkeigaku Zasshi; 2003; 105(4):393-7. PubMed ID: 12806900
[TBL] [Abstract][Full Text] [Related]
10. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.
Hu YY; He SS; Wang X; Duan QH; Grundke-Iqbal I; Iqbal K; Wang J
Am J Pathol; 2002 Apr; 160(4):1269-78. PubMed ID: 11943712
[TBL] [Abstract][Full Text] [Related]
11. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.
Arai H; Terajima M; Miura M; Higuchi S; Muramatsu T; Machida N; Seiki H; Takase S; Clark CM; Lee VM
Ann Neurol; 1995 Oct; 38(4):649-52. PubMed ID: 7574462
[TBL] [Abstract][Full Text] [Related]
12. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.
Vanmechelen E; Vanderstichele H; Davidsson P; Van Kerschaver E; Van Der Perre B; Sjögren M; Andreasen N; Blennow K
Neurosci Lett; 2000 May; 285(1):49-52. PubMed ID: 10788705
[TBL] [Abstract][Full Text] [Related]
13. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
[TBL] [Abstract][Full Text] [Related]
14. Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
Lewczuk P; Lelental N; Lachmann I; Holzer M; Flach K; Brandner S; Engelborghs S; Teunissen CE; Zetterberg H; Molinuevo JL; Mroczko B; Blennow K; Popp J; Parnetti L; Chiasserini D; Perret-Liaudet A; Spitzer P; Maler JM; Kornhuber J
J Alzheimers Dis; 2017; 55(1):159-170. PubMed ID: 27662295
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.
Ibach B; Binder H; Dragon M; Poljansky S; Haen E; Schmitz E; Koch H; Putzhammer A; Kluenemann H; Wieland W; Hajak G
Neurobiol Aging; 2006 Sep; 27(9):1202-11. PubMed ID: 16085339
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
Boban M; Grbić K; Mladinov M; Hof PR; Süssmair C; Ackl N; Stanić G; Bader B; Danek A; Simić G
Coll Antropol; 2008 Jan; 32 Suppl 1():31-6. PubMed ID: 18405055
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein.
Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
Russell CL; Mitra V; Hansson K; Blennow K; Gobom J; Zetterberg H; Hiltunen M; Ward M; Pike I
J Alzheimers Dis; 2017; 55(1):303-313. PubMed ID: 27636850
[TBL] [Abstract][Full Text] [Related]
20. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.
Vandermeeren M; Mercken M; Vanmechelen E; Six J; van de Voorde A; Martin JJ; Cras P
J Neurochem; 1993 Nov; 61(5):1828-34. PubMed ID: 8228996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
